Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories

Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. Although advances are being made towards earlier detection and the development of impactful targeted therapies and immunotherapies, the 5-year survival of patients with advanced disease is still below 20%. Ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Hynds, Robert E., Frese, Kristopher K., Pearce, David R., Grönroos, Eva, Dive, Caroline, Swanton, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881177/
https://www.ncbi.nlm.nih.gov/pubmed/33435818
http://dx.doi.org/10.1098/rsob.200247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881177/
https://www.ncbi.nlm.nih.gov/pubmed/33435818
http://dx.doi.org/10.1098/rsob.200247

Ejemplares similares